H. Huang

The Cost-Effectiveness of Bortezomib Plus Melphalan and Prednisone Versus Lenalidomide Plus Melphalan and Prednisone with Continuous Lenalidomide Maintenance Treatment for the Initial Treatment of Multiple Myeloma In the United States

D. Esseltine, M. Duh, A. Cakana, 2010 .

The Cost-Effectiveness of Bortezomib for the Initial Treatment of Multiple Myeloma in the United States.

D. Esseltine, L. Garrison, M. Duh, 2009 .

A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.

D. Esseltine, J. L. Marantz, D. Fullerton, 2007 .